| Examiner | Number of Cases | 3YGR |
|---|---|---|
| Examiner Belyavskyi | 506 | 51% |
| Examiner Driscoll | 12 | 25% |
| Examiner Dunn | 1 | 0% |
| Examiner George | 4 | 0% |
| Examiner Johansen | 208 | 34% |
| Examiner Juedes | 362 | 42% |
| Examiner Melchior | 9 | 11% |
| Examiner Ouspenski | 381 | 76% |
| Examiner Petrash | 15 | 20% |
| Examiner Skelding | 381 | 61% |
| Art Unit 1644 | 1879 | 54% |
| Number | Class Description |
|---|---|
| 424 | Drug, bio-affecting and body treating compositions |
| 435 | Chemistry: molecular biology and microbiology |
| 530 | Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof |
| 514 | Drug, bio-affecting and body treating compositions |
| 536 | Organic compounds -- part of the class 532-570 series |
| 506 | Combinatorial chemistry technology: method, library, apparatus |
| 436 | Chemistry: analytical and immunological testing |
| 600 | Surgery |
| 800 | Multicellular living organisms and unmodified parts thereof and related processes |
| 702 | Data processing: measuring, calibrating, or testing |
Art Unit 1644's grant rate is lower than that of Group 1640 and lower than that of the USPTO.
Below is the grant rate timeline for Art Unit 1644, where the timeline is relative to the date of the first office action. The three-year grant rate is the percentage of applications granted at three years after the first office action.
Disclaimer: We do not provide any guarantees as to the accuracy of the statistics presented above and under
no circumstances will we be liable for any outcome resulting from your reliance on the above statistics.